For decades, photodynamic therapy has promised precision in treating skin cancer, yet the treatment has been quietly undermined by a fundamental mismatch: the drug and the light it requires rarely reach the same depth at the same time. Researchers from Texas A&M University and the University of São Paulo have now proposed a quiet but consequential answer — dissolving microneedles that not only carry the therapeutic drug deeper into tissue, but reshape how light itself travels through the skin. In doing so, they have turned a passive delivery tool into an active participant in the physics of he
Dissolving microneedles could enhance photodynamic therapy for skin cancer
Light redirected in many directions instead of traveling in a straight line
Mark
Why does photodynamic therapy struggle so much with penetration? Isn't light supposed to travel through skin?
Mimi
Light does travel through skin, but it loses intensity as it goes deeper. And the drug applied on top has trouble reaching those same depths. You end up with a mismatch—the drug is shallow, the light is shallow, and deeper cancer cells survive.
Mark
So the microneedles solve both problems at once?
Mimi
Not exactly. The microneedles deliver the drug deeper into the tissue. But this new work shows they also do something unexpected with light—they scatter it in multiple directions instead of letting it travel in a straight line. That scattering helps light reach areas it wouldn't normally reach.
Mark
How does a tiny needle scatter light?
Mimi
Through internal reflections and bouncing. The pyramid shape acts like a miniature prism. Light enters, bounces around inside the needle, and exits in many directions at once. It's like the difference between a flashlight beam and a lamp that spreads light all around.
Mark
Could this work in actual tumors, or is this just lab theory?
Mimi
That's the open question. They tested it in simplified setups with lasers and arrays. Real tissue is messier—it has blood, pigment, irregular surfaces. They need to test in actual tissue models before they know if the effect holds up in practice.
Mark
If it does work, what changes for patients?
Mimi
Potentially deeper treatment, more complete destruction of cancer cells, and fewer recurrences. It could also make treatment simpler—one device doing two jobs instead of two separate steps.
O Pulso
- Photodynamic therapy's core promise has long been compromised by the inability to reliably deliver both drug and light to the same cancerous tissue, leaving deeper lesions undertreated and vulnerable to recurrence.
- Pyramid-shaped dissolving microneedles, when illuminated with a laser, were found to scatter light in multiple directions rather than allowing it to pass straight through — an unexpected optical behavior that could fundamentally change how treatment light reaches tissue.
- A mathematical model developed by the team suggests that arrays of thousands of microneedle tips could meaningfully reduce the intensity drop-off that normally limits how deep therapeutic light can penetrate.
- The research opens the door to a dual-function device — one that simultaneously releases photosensitive drugs and redistributes light — ensuring both reach the same location at the same moment.
- The findings remain at the laboratory stage, with validation in tissue models and preclinical systems still required before the approach can be assessed for real-world clinical use.
For decades, photodynamic therapy has promised precision in treating skin cancer, yet the treatment has been quietly undermined by a fundamental mismatch: the drug and the light it requires rarely reach the same depth at the same time. Researchers from Texas A&M University and the University of São Paulo have now proposed a quiet but consequential answer — dissolving microneedles that not only carry the therapeutic drug deeper into tissue, but reshape how light itself travels through the skin. In doing so, they have turned a passive delivery tool into an active participant in the physics of healing.
Photodynamic therapy rests on an elegant premise: a light-sensitive drug and a precise wavelength of light, arriving together, can selectively destroy cancer cells while leaving surrounding healthy tissue intact. For certain skin cancers, it has become a compelling option — but a stubborn limitation has always shadowed it. Drugs applied to the skin rarely penetrate deeply enough. Light loses intensity as it moves through tissue. And the two must converge on the same location for treatment to work. When they don't, cancer cells survive.
Researchers at Texas A&M University's Biomedical Engineering program and the Sao Carlos Institute of Physics at the University of São Paulo have now published work in the Journal of Biomedical Optics suggesting that dissolving microneedles — biodegradable, sub-millimeter structures that painlessly pierce the skin's outer layer before gradually dissolving — could address both failures at once. Earlier studies had already shown that microneedles loaded with aminolevulinic acid, a standard photodynamic therapy drug, could deliver treatment more deeply and evenly than topical creams. This research asked a further question: could the needles themselves improve how light moves through tissue?
To test this, the team fabricated arrays of hundreds of pyramid-shaped microneedles and illuminated them with a green laser, photographing and analyzing the light that emerged at various angles. The result was striking. Rather than transmitting light in a straight line, the microneedles redirected it in many directions through internal reflections and scattering, producing a nearly uniform, multidirectional illumination pattern from the needle tips. A mathematical model then suggested that thousands of such tips working together could significantly reduce the intensity drop-off that normally confines effective treatment to shallow lesions.
The practical implications are considerable. Uneven light distribution leaves pockets of tissue undertreated, allowing cancer cells to persist. A device that spreads light more uniformly could activate the photosensitive drug across a larger volume of tissue. The researchers envision either a two-step system — drug-loaded needles followed by light-optimizing needles — or a single device performing both functions simultaneously. Optical measurements were conducted in simplified laboratory conditions, and studies in tissue models and preclinical systems remain necessary. But the findings suggest that these small dissolving structures may quietly expand what photodynamic therapy can reach.
Photodynamic therapy works on a simple principle: a light-sensitive drug and a specific wavelength of light, working together, can destroy cancer cells. For certain skin cancers, it has become an attractive option because it can target diseased tissue while sparing the healthy skin around it. But the treatment has always faced a stubborn problem. The drug needs to reach the tumor. The light needs to reach the tumor. And they need to reach the same place. In practice, this rarely happens cleanly. Drugs applied to the skin struggle to penetrate deeply enough. Light, meanwhile, loses intensity as it travels through tissue, which means treatment is confined to relatively shallow lesions. The result is incomplete destruction of cancer cells and the possibility of recurrence.
Researchers at Texas A&M University's Biomedical Engineering program and the Sao Carlos Institute of Physics at the University of São Paulo have proposed a solution that tackles both problems simultaneously. Their work, published in the Journal of Biomedical Optics, centers on dissolving microneedles—tiny structures, smaller than a millimeter, made from biodegradable polymers that painlessly pierce the skin's outer layer and gradually dissolve after insertion. The team had already demonstrated in earlier studies that microneedles loaded with aminolevulinic acid, a drug commonly used in photodynamic therapy, could deliver treatment more deeply and evenly into skin tumors than traditional creams. This time, they asked a different question: could the microneedles themselves improve how light travels through tissue?
To find out, they fabricated arrays containing hundreds of pyramid-shaped microneedles and illuminated them with a green laser. By photographing the light emerging from the arrays at different angles and analyzing the images, they mapped how the structures altered the path of incoming light. What they discovered was unexpected. Instead of allowing light to travel in a straight line, the microneedles redirected it in many directions through a combination of internal reflections and scattering. Light emerging from the needle tips was distributed much more evenly than light passing through the spaces between them. Measurements showed that light from the microneedle tips maintained similar intensity across a range of viewing angles, producing a nearly uniform, multidirectional pattern of illumination.
The researchers then developed a mathematical model to examine how thousands of microneedle tips might distribute light inside tissue. Their analysis suggests that this broader scattering pattern could reduce the rapid loss of light intensity typically seen with standard directed illumination. In practical terms, more of the treatment light may reach areas that are difficult to illuminate using conventional approaches. For photodynamic therapy, this matters enormously. Successful treatment depends not only on the amount of light delivered but also on how evenly that light activates the photosensitive drug throughout the lesion. Uneven illumination can leave pockets of tissue insufficiently treated, allowing cancer cells to survive. By helping light spread more uniformly, microneedles may improve activation of the therapy across a larger volume of tissue.
The technology could be deployed in two ways. One approach would use drug-loaded microneedles first, followed by a second microneedle array designed specifically to improve light delivery. Another possibility is a single microneedle system that performs both functions simultaneously, delivering the drug while also guiding and redistributing light. Such a dual-function device could simplify treatment and improve precision by ensuring that drug release and light exposure occur in the same location at the same time. The researchers acknowledge that their optical measurements were performed in a simplified laboratory setup rather than living tissue. Additional studies in tissue models and preclinical systems will be needed to determine how much the light-redistribution effect improves treatment in real-world conditions. Still, the findings suggest that dissolving microneedles could extend the reach of photodynamic therapy and improve treatment of skin cancers that are currently difficult to treat with light alone.
Citações Notáveis
Light emerging from the needle tips was distributed much more evenly than light passing through the spaces between them— Research team findings
Quer a matéria completa?
Leia o original em News-Medical ↗
Health & Medicine